Parkinson disease. Individualizing therapy.
D000368:Aged; D001971:Bromocriptine / Q000009:adverse effects / Q000627:therapeutic use; D002230:Carbidopa / Q000008:administration & dosage / Q000627:therapeutic use; D002493:Central Nervous System Diseases / Q000175:diagnosis; D003937:Diagnosis, Differential; D005684:Gait; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D009043:Motor Activity; D010300:Parkinson Disease / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology*; D011605:Psychoses, Substance-Induced; D014202:Tremor / Q000188:drug therapy / Q000503:physiopathology
D001971:Bromocriptine; D007980:Levodopa; D002230:Carbidopa